BioCentury
ARTICLE | Clinical News

Oxford Biomedica to begin TroVax trials

January 2, 2001 8:00 AM UTC

Oxford Biomedica (LSE:OXB) will begin Phase I/II trials of its TroVax therapeutic cancer vaccine in patients with colorectal cancer. The vaccine provides viral delivery of tumor-associated antigens, a...